Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic disease
The carotid body (CB) is the main peripheral chemoreceptor that senses the arterial PO2, PCO2 and pH. In response to hypoxemia, hypercapnia and acidosis, carotid chemosensory discharge elicits reflex respiratory, autonomic and cardiovascular adjustments. The classical construct considers the CB as t...
Guardado en:
Autores principales: | , , , |
---|---|
Lenguaje: | English |
Publicado: |
Sociedad de Biología de Chile
2016
|
Materias: | |
Acceso en línea: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100013 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:scielo:S0716-97602016000100013 |
---|---|
record_format |
dspace |
spelling |
oai:scielo:S0716-976020160001000132016-12-01Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic diseaseIturriaga,RodrigoDel Rio,RodrigoIdiaquez,JuanSomers,Virend K. Autonomic dysfunction Carotid body Heart failure Metabolic syndrome Obstructive sleep apnea Sympathetic activation The carotid body (CB) is the main peripheral chemoreceptor that senses the arterial PO2, PCO2 and pH. In response to hypoxemia, hypercapnia and acidosis, carotid chemosensory discharge elicits reflex respiratory, autonomic and cardiovascular adjustments. The classical construct considers the CB as the main peripheral oxygen sensor, triggering reflex physiological responses to acute hypoxemia and facilitating the ventilatory acclimation to chronic hypoxemia at high altitude. However, a growing body of experimental evidence supports the novel concept that an abnormally enhanced CB chemosensory input to the brainstem contributes to overactivation of the sympathetic nervous system, and consequent pathology. Indeed, the CB has been implicated in several diseases associated with increases in central sympathetic outflow. These include hypertension, heart failure, sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome. Indeed, ablation of the CB has been proposed for the treatment of severe and resistant hypertension in humans. In this review, we will analyze and discuss new evidence supporting an important role for the CB chemoreceptor in the progression of autonomic and cardiorespiratory alterations induced by heart failure, obstructive sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome.info:eu-repo/semantics/openAccessSociedad de Biología de ChileBiological Research v.49 20162016-01-01text/htmlhttp://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100013en10.1186/s40659-016-0073-8 |
institution |
Scielo Chile |
collection |
Scielo Chile |
language |
English |
topic |
Autonomic dysfunction Carotid body Heart failure Metabolic syndrome Obstructive sleep apnea Sympathetic activation |
spellingShingle |
Autonomic dysfunction Carotid body Heart failure Metabolic syndrome Obstructive sleep apnea Sympathetic activation Iturriaga,Rodrigo Del Rio,Rodrigo Idiaquez,Juan Somers,Virend K. Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic disease |
description |
The carotid body (CB) is the main peripheral chemoreceptor that senses the arterial PO2, PCO2 and pH. In response to hypoxemia, hypercapnia and acidosis, carotid chemosensory discharge elicits reflex respiratory, autonomic and cardiovascular adjustments. The classical construct considers the CB as the main peripheral oxygen sensor, triggering reflex physiological responses to acute hypoxemia and facilitating the ventilatory acclimation to chronic hypoxemia at high altitude. However, a growing body of experimental evidence supports the novel concept that an abnormally enhanced CB chemosensory input to the brainstem contributes to overactivation of the sympathetic nervous system, and consequent pathology. Indeed, the CB has been implicated in several diseases associated with increases in central sympathetic outflow. These include hypertension, heart failure, sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome. Indeed, ablation of the CB has been proposed for the treatment of severe and resistant hypertension in humans. In this review, we will analyze and discuss new evidence supporting an important role for the CB chemoreceptor in the progression of autonomic and cardiorespiratory alterations induced by heart failure, obstructive sleep apnea, chronic obstructive pulmonary disease and metabolic syndrome. |
author |
Iturriaga,Rodrigo Del Rio,Rodrigo Idiaquez,Juan Somers,Virend K. |
author_facet |
Iturriaga,Rodrigo Del Rio,Rodrigo Idiaquez,Juan Somers,Virend K. |
author_sort |
Iturriaga,Rodrigo |
title |
Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic disease |
title_short |
Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic disease |
title_full |
Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic disease |
title_fullStr |
Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic disease |
title_full_unstemmed |
Carotid body (Thermoreceptors, sympathetic neural activation, and cardiometabolic disease |
title_sort |
carotid body (thermoreceptors, sympathetic neural activation, and cardiometabolic disease |
publisher |
Sociedad de Biología de Chile |
publishDate |
2016 |
url |
http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0716-97602016000100013 |
work_keys_str_mv |
AT iturriagarodrigo carotidbodythermoreceptorssympatheticneuralactivationandcardiometabolicdisease AT delriorodrigo carotidbodythermoreceptorssympatheticneuralactivationandcardiometabolicdisease AT idiaquezjuan carotidbodythermoreceptorssympatheticneuralactivationandcardiometabolicdisease AT somersvirendk carotidbodythermoreceptorssympatheticneuralactivationandcardiometabolicdisease |
_version_ |
1718441549645217792 |